4.7 Article

Dysfunctional EAT thickness may promote maladaptive heart remodeling in CVD patients through the ST2-IL33 system, directly related to EPAC protein expression

Journal

SCIENTIFIC REPORTS
Volume 9, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-019-46676-w

Keywords

-

Funding

  1. Italian Ministry of Health Ricerca Corrente [9.12.1]
  2. Fondazione E. A. Fiera Internazionale di Milano

Ask authors/readers for more resources

Dysfunctional epicardial adipose tissue (EAT) secretome can influence the heart's stretch response. However, the molecular mechanisms are still poorly understood. The aim of this study was to clarify how dysfunctional EAT promotes maladaptive heart remodeling in cardiovascular disease (CVD) through ST2 production associated with exchange protein directly activated by cAMP (EPAC) proteins. A series of 55 CVD males were enrolled and their EAT thickness, LV mass and volumes were measured by echocardiography. Blood, plasma and EAT biopsies were collected for molecular and proteomic assays. Taking EAT thickness as a continuous variable there was a direct correlation between the ST2 cardiac stretch mediator and EAT thickness (r = 0.54, p < 0.01) and an inverse relation between the ST2 gene and IL-33 expression (r -0.50, p < 0.01). In the CVD population EPAC2 expression directly correlated with the ST2 gene (r = 0.74, p < 0.0001) causing an ST2/IL-33 system local (p < 0.001) and systemic (sST2 = 57.33 +/- 3.22 and IL-33 = 0.53 +/- 017 pg/mL; p < 0.0001) protein imbalance associated with maladaptive remodeling. This indicated that dysfunctional EAT is a source of both EPAC and ST2 protein and an EPAC2 isoform seems involved in ST2 production in adipose tissue. Both EPAC2 and ST2 expression were directly related to maladaptive heart remodeling indices, suggesting EAT measurements could be useful in the early assessment of CVD complications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Unveiling IL-33/ST2 Pathway Unbalance in Cardiac Remodeling Due to Obesity in Zucker Fatty Rats

Clementina Sitzia, Elena Vianello, Elena Dozio, Marta Kalousova, Tomas Zima, Stefano Brizzola, Paola Roccabianca, Gabriella Tedeschi, John Lamont, Lorenza Tacchini, Massimiliano Marco Corsi-Romanelli

Summary: Obesity is associated with cardiovascular disease and mortality, and adipose-derived IL-33 plays a role in cardiac remodeling. The dysregulation of IL-33/ST2 signaling affects Epac proteins and myocardial gene expression, leading to pro-fibrotic effects. Ghrelin-induced IL-33 secretion counteracts fibrosis and influences transcription factor expression. The effect of IL-33 signaling depends on cell types' origin and the balancing of ST2 isoforms.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Editorial Material Cardiac & Cardiovascular Systems

Editorial comments: focus on cardiac rehabilitation and prevention

Geza Halasz, Francesco Bandera, Massimo F. Piepoli

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cell Biology

Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study

Paolo Molinari, Lara Caldiroli, Elena Dozio, Roberta Rigolini, Paola Giubbilini, Francesca Maria Ida Carminati, Giuseppe Castellano, Massimiliano M. Corsi M. Romanelli, Simone Vettoretti

Summary: In patients with chronic kidney disease (CKD), advanced glycation end products (AGEs) are associated with specific components of frailty, including an inverse association with BMI and a direct association with gait test time. AGEs are also associated with involuntary weight loss.

CELLS (2023)

Editorial Material Cardiac & Cardiovascular Systems

Focus on sport cardiology and exercise

Geza Halasz, Francesco Bandera, Massimo Piepoli

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Focus on risk factors and prediction

Geza Halasz, Francesco Bandera, Massimo Piepoli

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Editorial comments: Focus on lipid, obesity, and eating behaviour

Geza Halasz, Francesco Bandera, Massimo Piepoli

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Focus on cardiomyopathy and heart failure

Geza Halasz, Francesco Bandera, Massimo Piepoli

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Human epicardial adipose tissue expresses glucose-dependent insulinotropic polypeptide, glucagon, and glucagon-like peptide-1 receptors as potential targets of pleiotropic therapies

Alexis Elias Malavazos, Gianluca Iacobellis, Elena Dozio, Sara Basilico, Angelica Di Vincenzo, Carola Dubini, Lorenzo Menicanti, Elena Vianello, Chiara Meregalli, Chiara Ruocco, Maurizio Ragni, Francesco Secchi, Pietro Spagnolo, Serenella Castelvecchio, Lelio Morricone, Silvio Buscemi, Antonio Giordano, Jeffrey J. Goldberger, Michele Carruba, Saverio Cinti, Massimiliano Marco Corsi Romanelli, Enzo Nisoli

Summary: Human epicardial adipose tissue (EAT) is a unique and multifunctional fat compartment of the heart that can directly interact with the myocardium. It plays a key role in the development and progression of coronary artery disease, atrial fibrillation, and heart failure. Targeting EAT through G-protein-coupled receptors, such as GLP-1R agonists, can be a novel therapeutic approach.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Endurance training: what is the expected left ventricle remodelling?

Francesco Bandera

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Editorial Material Cardiac & Cardiovascular Systems

Issue 30.08 focus on diabetes mellitus and cardiometabolic disorders

Geza Halasz, Francesco Bandera, Guido Giacalone, Massimo Piepoli

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Immunology

Impact of BNT162b2 Booster Dose on SARS-CoV-2 Anti-Trimeric Spike Antibody Dynamics in a Large Cohort of Italian Health Care Workers

Laura V. Renna, Fabio Bertani, Alessandro Podio, Sara Boveri, Matteo Carrara, Arianna Pinton, Valentina Milani, Giovanni Spuria, Angelica F. Nizza, Sara Basilico, Carola Dubini, Ambra Cerri, Lorenzo Menicanti, Massimiliano M. Corsi-Romanelli, Alexis E. Malavazos, Rosanna Cardani

Summary: Accurate studies on the dynamics of Pfizer-Biontech BNT162b2-induced antibodies are crucial for tailoring booster dose administration. Little is known about the durability and kinetics of antibody titers months after receiving a booster dose. In this study, the dynamic of anti-Trimeric Spike (anti-TrimericS) IgG titer was examined in healthcare workers who had received two vaccine doses plus a booster dose. The results suggest that the booster dose increases anti-TrimericS IgG production and levels out differences in immunogenicity based on infection status, age, and sex.

VACCINES (2023)

Review Biochemistry & Molecular Biology

Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease

Elena Dozio, Lara Caldiroli, Paolo Molinari, Giuseppe Castellano, Nicholas Walter Delfrate, Massimiliano Marco Corsi Romanelli, Simone Vettoretti

Summary: Advanced glycation end products (AGEs) are aging products that accumulate in chronic kidney disease (CKD) due to increased production, reduced excretion, and imbalance between oxidant/antioxidant capacities. This review aims to summarize the knowledge of AGEs in CKD onset and progression, focusing on related disorders and mortality. The role of AGEs as etiopathogenetic molecules and potential markers or therapeutic targets will be discussed.

ANTIOXIDANTS (2023)

No Data Available